Skip to main content

Table 2 Significance of subunit expression on recurrence free survival (RFS) and overall survival (OS)

From: Initiation and elongation factor co-expression correlates with recurrence and survival in epithelial ovarian cancer

  Number of evaluated samples CS score (SD) RFS OS
eIF6 eIF6 cytoplasm 75 6.24 (2.7) U = 640; p < .742 U = 600; p < .876
eIF6 nuclear 75 N/A N/A N/A
eIF6 normal stroma 60 2.2 (1.0) U = 372; p < .638 U = 278; p < .410
eIF6 cancer stroma 75 2.3 (1.0) U = 648; p < .821 U = 599; p < .872
eIF5B eIF5B cytoplasm 74 1.8 (1.9) U = 597; p < .525 U = 566; p < .685
eIF5B nuclear 74 N/A N/A N/A
eIF5B normal stroma 50 1.96 (1.3) U = 236; p < .305 U = 228; p < .749
eIF5B cancer stroma 73 2.1 (1.5) U = 483; p < .059 U = 536; p < .507
eIF5A eIF5A cytoplasm 75 4.1 (2.6) U = 531; p < .102 U = 469; p < .073
eIF5A nuclear 75 10.7 (3.4) U = 546; p < .025 U = 503; p < .036
eIF5A normal stroma 57 4.3 (1.9) U = 332; p < .341 U = 310; p < .510
eIF5A cancer stroma 74 3.9 (1.9) U = 481; p < .043 U = 446; p < .048
eIF2G eIF2G cytoplasm 75 5.7 (2.3) U = 562; p < .209 U = 463; p < .063
eIF2G nuclear 75 5.9 (2.5) U = 608; p < .481 U = 439; p < .031
eIF2G normal stroma 52 4.2 (1.9) U = 261; p < .314 U = 247; p < .466
eIF2G cancer stroma 75 3.2 (1.8) U = 647; p < .820 U = 482; p < .122
eEF1A1 eEF1A1 cytoplasm 75 9.0 (2.7) U = 553; p < .177 U = 516; p < .235
eEF1A1 nuclear 75 N/A N/A N/A
eEF1A1 normal stroma 54 3.3 (2.7) U = 308; p < .424 U = 278; p < .379
eEF1A1 cancer stroma 72 4.3 (3.4) U = 573; p < .611 U = 387; p < .021
eIF2α eIF2α cytoplasm 75 9.5 (2.4) U = 629; p < .640 U = 581; p < .771
eIF2α nuclear 75 N/A N/A N/A
eIF2α normal stroma 66 2.8 (1.6) U = 443; p < .260 U = 612; p < .086
eIF2α cancer stroma 75 3.1 (1.1) U = 598; p < .425 U = 589; p < .710